Inogen (NASDAQ:INGN) Now Covered by B. Riley
B. Riley began coverage on shares of Inogen (NASDAQ:INGN – Free Report) in a report issued on Monday morning, MarketBeat.com reports. The firm issued a buy rating and a $14.00 price objective on the medical technology company’s stock. Several other analysts have also issued reports on the stock. Needham & Company LLC upgraded shares of […]
B. Riley began coverage on shares of Inogen (NASDAQ:INGN – Free Report) in a report issued on Monday morning, MarketBeat.com reports. The firm issued a buy rating and a $14.00 price objective on the medical technology company’s stock. Several other analysts have also issued reports on the stock. Needham & Company LLC upgraded shares of […]
